/Investor DB

Necessary Ventures — 2026 Investments

2 investments dated 2026 · listed companies and verified rows first · show all

EnsoDataensodata.comin𝕏Jun 2026 · $9M

Enso Data provides AI-powered analysis of physiological waveforms, particularly sleep studies, to enable clinical diagnosis and patient monitoring.

AI & Machine LearningDigital HealthHealthtechMedical DevicesMadison, US

Christopher Fernandez(Executive Officer, Director)inChristopher R. Fernandez(Executive Officer, Director)inSam Rusk(Co-Founder & CAIO)inNick Glattard(Co-Founder & CTO)inJustin Mortara(CEO & President)inMatthew D Dobereiner(Executive Officer)

Co-investorsColle Capital Partnersgener8torGreat North VenturesHealthX VenturesQuesta CapitalSupermoon Capital+5 more

Nitranitra.comin𝕏Mar 2026

Nitra provides a card, lending, and back-office platform built specifically for independent medical practices including ophthalmology, dental, aesthetics, and fertility clinics.

Enterprise SoftwareFintechHealthtechNew York, US

Tim Hwang(CEO)in

Co-investorsAAF Management Ltd.AppWorks VenturesDunamu & PartnersExpaFoundersXFoundersX Ventures+24 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.